Cargando…
Immunotherapy for extensive-stage small-cell lung cancer: current landscape and future perspectives
Small-cell lung cancer (SCLC) is a fatal subtype of lung cancer characterized by high aggressiveness, poor prognosis, and limited treatment options. For the first time in more than three decades, it has been demonstrated that the addition of immunotherapy to chemotherapy improved the survival of pat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175664/ https://www.ncbi.nlm.nih.gov/pubmed/37188176 http://dx.doi.org/10.3389/fonc.2023.1142081 |